8-K: NRX Pharmaceuticals, Inc. — Item 1.01 Entry into a Material Definitive Agreement
Filed: 2026-10-05 AccNo: 0001437749-26-032042 Size: 210 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibi
Filed: 2026-10-05 AccNo: 0001437749-26-032042 Size: 210 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibi